Clinical Trials · NCT04252612
Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study
- Phase
- EARLY_Phase 1
- Recruitment status
- Withdrawn
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Enrollment
- 0
- Start date
- Jan 2020
- Locations
- 1 site, United States
- Primary endpoint
- Participant Compliance